Twist Bioscience at the European
Symposium of Human Genetics 2026

We're excited to join innovative minds at ESHG 2026 in Gothenburg! Twist Bioscience is proud to
be at the forefront of this incredible gathering for groundbreaking genomics exploration.

 

ESHG Quick Guide

June 13–16, 2026   
Dates                                                 Learn more
 
Svenska Mässan   
Gothenburg, Sweden                        Get directions
 
Booth #508   
Twist Booth Location                        Check the floorplan

What to expect from Twist Bioscience

Join us at Booth #508 and let’s discuss how Twist Bioscience can empower your genetics and genomics research.


Our experts will be on hand to explore your projects and guide you through a wide range of solutions based on your sample types: FFPE, cfDNA, ctDNA, or RNAseq, and experimental goals. Discover our high-quality exome solutions; let us guide you through IVDR compliance; or learn about our enrichment solutions.

Learn how Twist technologies can revolutionize your lab

ESHG 2026

Corporate Session

“Superior uniformity, deeper insights: The Twist Bioscience NGS advantage”
Monday, 15 June 2026
12.15-13.30 CEST
Room: A5

Introduction: Superior uniformity, deeper insights - The Twist Bioscience NGS advantage

Maria Harbo headshot

Maria Harbo, PhD

Field Application Scientist at Twist Bioscience, Oslo, Norway

Inherited cancer diagnostics using Targeted Long-read and Short-read Sequencing

Claes Ladenvall headshot

Claes Ladenvall, PhD

Department of Immunology, Genetics and Pathology, and Department of Clinical Genetics, Uppsala University Hospital, Uppsala, Sweden

Sequencing Strategies in Diagnostics Research: A Focus on Twist Technologies

Isabell Schumann headshot

Dr. rer. nat. Isabell Schumann

Centre of Medical Genetics, Department of Medical Genetics, Münster, Germany

 

Starting with an opening overview from Maria Harbo, PhD, Field Application Scientist at Twist Bioscience, we will explore how silicon-based synthesis technology fundamentally transforms the NGS workflow. This technological foundation is brought to life through the work of two pioneering researchers.

Claes Ladenvall, PhD, of Uppsala University Hospital, will share how targeted sequencing strategies - utilizing both long- and short-read data - are being applied to the complexities of inherited cancer diagnostics.

Following this, Dr. Isabell Schumann from the Centre of Medical Genetics, Münster, will discuss specific sequencing strategies in diagnostic research, focusing on how these tools enable laboratories to tackle complex genomic questions while significantly reducing sequencing costs.

From unraveling genomic architecture to accelerating the next generation of molecular diagnostics, this session highlights how silicon-based synthesis enables deeper insights with higher efficiency. Join us to see how these innovations are not only optimizing laboratory performance but fundamentally expanding the boundaries of what is possible in genomic research.

ESHG 2026 scene

Posters

Poster

Development of an optimized workflow for sensitive variant detection in FFPE-damages samples

Tina Han, Director, Applications & Business Development, Twist Bioscience

Learn more

Poster

Integrated RNA-seq and DNA-seq analysis in a clinical routine diagnostic laboratory using a...

Mansour Hendili Lamisse, CHU Montpellier

Learn more